Exact Sciences had its Relative Strength (RS) Rating upgraded from 89 to 92 Friday. Trading in a tight formation since the recent gap-up in higher traffic.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. This unique rating tracks market leadership by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 at the beginning of a new climb.
See How IBD Helps You Make More Money In Stocks
While it's not currently an ideal time to jump in, see if the stock is able to establish and enter a buying range in heavy trade.
Exact Sciences reported 0% EPS growth in the latest quarterly report, while sales growth came in at 15%.
The company earns the No. 71 rank among its peers in the Medical-Biomed/Biotech industry group. Catalyst Pharmaceuticals, Genmab ADR and Harmony Biosciences are among the top 5 highly rated stocks within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
